{"id":"https://openalex.org/W2013439461","doi":"https://doi.org/10.1097/00002826-198910000-00006","title":"Glycine Adjuvant Therapy to Conventional Neuroleptic Treatment in Schizophrenia","display_name":"Glycine Adjuvant Therapy to Conventional Neuroleptic Treatment in Schizophrenia","publication_year":1989,"publication_date":"1989-10-01","ids":{"openalex":"https://openalex.org/W2013439461","doi":"https://doi.org/10.1097/00002826-198910000-00006","mag":"2013439461","pmid":"https://pubmed.ncbi.nlm.nih.gov/2611765"},"language":"en","primary_location":{"id":"doi:10.1097/00002826-198910000-00006","doi":"https://doi.org/10.1097/00002826-198910000-00006","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00002826-198910000-00006","pdf_url":null,"source":{"id":"https://openalex.org/S3349026","display_name":"Clinical Neuropharmacology","issn_l":"0362-5664","issn":["0362-5664","1537-162X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Neuropharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5048409402","display_name":"Richard B. Rosse","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I125043107","display_name":"Nathan Kline Institute for Psychiatric Research","ror":"https://ror.org/01s434164","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I125043107"]},{"id":"https://openalex.org/I1322918889","display_name":"United States Department of Veterans Affairs","ror":"https://ror.org/05rsv9s98","country_code":"US","type":"government","lineage":["https://openalex.org/I1322918889"]},{"id":"https://openalex.org/I184565670","display_name":"Georgetown University","ror":"https://ror.org/05vzafd60","country_code":"US","type":"education","lineage":["https://openalex.org/I184565670"]},{"id":"https://openalex.org/I2799886695","display_name":"Veterans Health Administration","ror":"https://ror.org/05eq41471","country_code":"US","type":"government","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695"]},{"id":"https://openalex.org/I2799903593","display_name":"Georgetown University Medical Center","ror":"https://ror.org/00hjz7x27","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799903593"]},{"id":"https://openalex.org/I4210154891","display_name":"Washington DC VA Medical Center","ror":"https://ror.org/050fz5z96","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210111569","https://openalex.org/I4210154891"]},{"id":"https://openalex.org/I4405285767","display_name":"Veterans Administration","ror":"https://ror.org/006ym5897","country_code":"US","type":"government","lineage":["https://openalex.org/I1322918889","https://openalex.org/I4405285767"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Richard B. Rosse","raw_affiliation_strings":["Psychiatry Service, Veterans Administration Medical Center, Washington, D.C. 20422","Psychiatry Service (688/116A), Veterans Administration Medical Center and \u2020Department of Psychiatry, Georgetown University School of Medicine, Washington, D.C., and \u2021Center for Neurochemistry, Nathan S. Kline Research Institute, Wards Island, New York City, New York, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatry Service, Veterans Administration Medical Center, Washington, D.C. 20422","institution_ids":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210154891","https://openalex.org/I4405285767"]},{"raw_affiliation_string":"Psychiatry Service (688/116A), Veterans Administration Medical Center and \u2020Department of Psychiatry, Georgetown University School of Medicine, Washington, D.C., and \u2021Center for Neurochemistry, Nathan S. Kline Research Institute, Wards Island, New York City, New York, U.S.A","institution_ids":["https://openalex.org/I125043107","https://openalex.org/I1322918889","https://openalex.org/I184565670","https://openalex.org/I2799903593","https://openalex.org/I4405285767"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022333420","display_name":"Susan K. Theut","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I125043107","display_name":"Nathan Kline Institute for Psychiatric Research","ror":"https://ror.org/01s434164","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I125043107"]},{"id":"https://openalex.org/I1322918889","display_name":"United States Department of Veterans Affairs","ror":"https://ror.org/05rsv9s98","country_code":"US","type":"government","lineage":["https://openalex.org/I1322918889"]},{"id":"https://openalex.org/I184565670","display_name":"Georgetown University","ror":"https://ror.org/05vzafd60","country_code":"US","type":"education","lineage":["https://openalex.org/I184565670"]},{"id":"https://openalex.org/I2799903593","display_name":"Georgetown University Medical Center","ror":"https://ror.org/00hjz7x27","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799903593"]},{"id":"https://openalex.org/I4405285767","display_name":"Veterans Administration","ror":"https://ror.org/006ym5897","country_code":"US","type":"government","lineage":["https://openalex.org/I1322918889","https://openalex.org/I4405285767"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Susan K. Theut","raw_affiliation_strings":["Psychiatry Service (688/116A), Veterans Administration Medical Center and \u2020Department of Psychiatry, Georgetown University School of Medicine, Washington, D.C., and \u2021Center for Neurochemistry, Nathan S. Kline Research Institute, Wards Island, New York City, New York, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatry Service (688/116A), Veterans Administration Medical Center and \u2020Department of Psychiatry, Georgetown University School of Medicine, Washington, D.C., and \u2021Center for Neurochemistry, Nathan S. Kline Research Institute, Wards Island, New York City, New York, U.S.A","institution_ids":["https://openalex.org/I125043107","https://openalex.org/I1322918889","https://openalex.org/I184565670","https://openalex.org/I2799903593","https://openalex.org/I4405285767"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036231030","display_name":"Miriam Banay\u2010Schwartz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I125043107","display_name":"Nathan Kline Institute for Psychiatric Research","ror":"https://ror.org/01s434164","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I125043107"]},{"id":"https://openalex.org/I1322918889","display_name":"United States Department of Veterans Affairs","ror":"https://ror.org/05rsv9s98","country_code":"US","type":"government","lineage":["https://openalex.org/I1322918889"]},{"id":"https://openalex.org/I184565670","display_name":"Georgetown University","ror":"https://ror.org/05vzafd60","country_code":"US","type":"education","lineage":["https://openalex.org/I184565670"]},{"id":"https://openalex.org/I2799903593","display_name":"Georgetown University Medical Center","ror":"https://ror.org/00hjz7x27","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799903593"]},{"id":"https://openalex.org/I4405285767","display_name":"Veterans Administration","ror":"https://ror.org/006ym5897","country_code":"US","type":"government","lineage":["https://openalex.org/I1322918889","https://openalex.org/I4405285767"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Miriam Banay-Schwartz","raw_affiliation_strings":["Psychiatry Service (688/116A), Veterans Administration Medical Center and \u2020Department of Psychiatry, Georgetown University School of Medicine, Washington, D.C., and \u2021Center for Neurochemistry, Nathan S. Kline Research Institute, Wards Island, New York City, New York, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatry Service (688/116A), Veterans Administration Medical Center and \u2020Department of Psychiatry, Georgetown University School of Medicine, Washington, D.C., and \u2021Center for Neurochemistry, Nathan S. Kline Research Institute, Wards Island, New York City, New York, U.S.A","institution_ids":["https://openalex.org/I125043107","https://openalex.org/I1322918889","https://openalex.org/I184565670","https://openalex.org/I2799903593","https://openalex.org/I4405285767"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077752572","display_name":"Michael P. Leighton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I125043107","display_name":"Nathan Kline Institute for Psychiatric Research","ror":"https://ror.org/01s434164","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I125043107"]},{"id":"https://openalex.org/I1322918889","display_name":"United States Department of Veterans Affairs","ror":"https://ror.org/05rsv9s98","country_code":"US","type":"government","lineage":["https://openalex.org/I1322918889"]},{"id":"https://openalex.org/I184565670","display_name":"Georgetown University","ror":"https://ror.org/05vzafd60","country_code":"US","type":"education","lineage":["https://openalex.org/I184565670"]},{"id":"https://openalex.org/I2799903593","display_name":"Georgetown University Medical Center","ror":"https://ror.org/00hjz7x27","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799903593"]},{"id":"https://openalex.org/I4405285767","display_name":"Veterans Administration","ror":"https://ror.org/006ym5897","country_code":"US","type":"government","lineage":["https://openalex.org/I1322918889","https://openalex.org/I4405285767"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Michael Leighton","raw_affiliation_strings":["Psychiatry Service (688/116A), Veterans Administration Medical Center and \u2020Department of Psychiatry, Georgetown University School of Medicine, Washington, D.C., and \u2021Center for Neurochemistry, Nathan S. Kline Research Institute, Wards Island, New York City, New York, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatry Service (688/116A), Veterans Administration Medical Center and \u2020Department of Psychiatry, Georgetown University School of Medicine, Washington, D.C., and \u2021Center for Neurochemistry, Nathan S. Kline Research Institute, Wards Island, New York City, New York, U.S.A","institution_ids":["https://openalex.org/I125043107","https://openalex.org/I1322918889","https://openalex.org/I184565670","https://openalex.org/I2799903593","https://openalex.org/I4405285767"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011453749","display_name":"Erminia Scarcella","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I125043107","display_name":"Nathan Kline Institute for Psychiatric Research","ror":"https://ror.org/01s434164","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I125043107"]},{"id":"https://openalex.org/I1322918889","display_name":"United States Department of Veterans Affairs","ror":"https://ror.org/05rsv9s98","country_code":"US","type":"government","lineage":["https://openalex.org/I1322918889"]},{"id":"https://openalex.org/I184565670","display_name":"Georgetown University","ror":"https://ror.org/05vzafd60","country_code":"US","type":"education","lineage":["https://openalex.org/I184565670"]},{"id":"https://openalex.org/I2799903593","display_name":"Georgetown University Medical Center","ror":"https://ror.org/00hjz7x27","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799903593"]},{"id":"https://openalex.org/I4405285767","display_name":"Veterans Administration","ror":"https://ror.org/006ym5897","country_code":"US","type":"government","lineage":["https://openalex.org/I1322918889","https://openalex.org/I4405285767"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Erminia Scarcella","raw_affiliation_strings":["Psychiatry Service (688/116A), Veterans Administration Medical Center and \u2020Department of Psychiatry, Georgetown University School of Medicine, Washington, D.C., and \u2021Center for Neurochemistry, Nathan S. Kline Research Institute, Wards Island, New York City, New York, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatry Service (688/116A), Veterans Administration Medical Center and \u2020Department of Psychiatry, Georgetown University School of Medicine, Washington, D.C., and \u2021Center for Neurochemistry, Nathan S. Kline Research Institute, Wards Island, New York City, New York, U.S.A","institution_ids":["https://openalex.org/I125043107","https://openalex.org/I1322918889","https://openalex.org/I184565670","https://openalex.org/I2799903593","https://openalex.org/I4405285767"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082435034","display_name":"Cynthia G. Cohen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I125043107","display_name":"Nathan Kline Institute for Psychiatric Research","ror":"https://ror.org/01s434164","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I125043107"]},{"id":"https://openalex.org/I1322918889","display_name":"United States Department of Veterans Affairs","ror":"https://ror.org/05rsv9s98","country_code":"US","type":"government","lineage":["https://openalex.org/I1322918889"]},{"id":"https://openalex.org/I184565670","display_name":"Georgetown University","ror":"https://ror.org/05vzafd60","country_code":"US","type":"education","lineage":["https://openalex.org/I184565670"]},{"id":"https://openalex.org/I2799903593","display_name":"Georgetown University Medical Center","ror":"https://ror.org/00hjz7x27","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799903593"]},{"id":"https://openalex.org/I4405285767","display_name":"Veterans Administration","ror":"https://ror.org/006ym5897","country_code":"US","type":"government","lineage":["https://openalex.org/I1322918889","https://openalex.org/I4405285767"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Cynthia G. Cohen","raw_affiliation_strings":["Psychiatry Service (688/116A), Veterans Administration Medical Center and \u2020Department of Psychiatry, Georgetown University School of Medicine, Washington, D.C., and \u2021Center for Neurochemistry, Nathan S. Kline Research Institute, Wards Island, New York City, New York, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatry Service (688/116A), Veterans Administration Medical Center and \u2020Department of Psychiatry, Georgetown University School of Medicine, Washington, D.C., and \u2021Center for Neurochemistry, Nathan S. Kline Research Institute, Wards Island, New York City, New York, U.S.A","institution_ids":["https://openalex.org/I125043107","https://openalex.org/I1322918889","https://openalex.org/I184565670","https://openalex.org/I2799903593","https://openalex.org/I4405285767"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5047021203","display_name":"Stephen I. Deutsch","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I125043107","display_name":"Nathan Kline Institute for Psychiatric Research","ror":"https://ror.org/01s434164","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I125043107"]},{"id":"https://openalex.org/I1322918889","display_name":"United States Department of Veterans Affairs","ror":"https://ror.org/05rsv9s98","country_code":"US","type":"government","lineage":["https://openalex.org/I1322918889"]},{"id":"https://openalex.org/I184565670","display_name":"Georgetown University","ror":"https://ror.org/05vzafd60","country_code":"US","type":"education","lineage":["https://openalex.org/I184565670"]},{"id":"https://openalex.org/I2799903593","display_name":"Georgetown University Medical Center","ror":"https://ror.org/00hjz7x27","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799903593"]},{"id":"https://openalex.org/I4405285767","display_name":"Veterans Administration","ror":"https://ror.org/006ym5897","country_code":"US","type":"government","lineage":["https://openalex.org/I1322918889","https://openalex.org/I4405285767"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Stephen I. Deutsch","raw_affiliation_strings":["Psychiatry Service (688/116A), Veterans Administration Medical Center and \u2020Department of Psychiatry, Georgetown University School of Medicine, Washington, D.C., and \u2021Center for Neurochemistry, Nathan S. Kline Research Institute, Wards Island, New York City, New York, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatry Service (688/116A), Veterans Administration Medical Center and \u2020Department of Psychiatry, Georgetown University School of Medicine, Washington, D.C., and \u2021Center for Neurochemistry, Nathan S. Kline Research Institute, Wards Island, New York City, New York, U.S.A","institution_ids":["https://openalex.org/I125043107","https://openalex.org/I1322918889","https://openalex.org/I184565670","https://openalex.org/I2799903593","https://openalex.org/I4405285767"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5011453749","https://openalex.org/A5022333420","https://openalex.org/A5047021203","https://openalex.org/A5048409402","https://openalex.org/A5077752572","https://openalex.org/A5082435034"],"corresponding_institution_ids":["https://openalex.org/I125043107","https://openalex.org/I1322918889","https://openalex.org/I184565670","https://openalex.org/I2799886695","https://openalex.org/I2799903593","https://openalex.org/I4210154891","https://openalex.org/I4405285767"],"apc_list":null,"apc_paid":null,"fwci":2.2035,"has_fulltext":false,"cited_by_count":101,"citation_normalized_percentile":{"value":0.86667403,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"12","issue":"5","first_page":"416","last_page":"424"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12770","display_name":"Amino Acid Enzymes and Metabolism","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glycine","display_name":"glycine","score":0.9980000257492065},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.7860000133514404},{"id":"https://openalex.org/keywords/adjunctive-therapy","display_name":"adjunctive therapy","score":0.824999988079071},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.8349999785423279},{"id":"https://openalex.org/keywords/nmda-receptor","display_name":"NMDA receptor","score":0.9229999780654907},{"id":"https://openalex.org/keywords/glutamatergic-neurotransmission","display_name":"glutamatergic neurotransmission","score":0.9350000023841858},{"id":"https://openalex.org/keywords/extrapyramidal-symptoms","display_name":"extrapyramidal symptoms","score":0.6629999876022339},{"id":"https://openalex.org/keywords/blood-brain-barrier-penetration","display_name":"blood-brain barrier penetration","score":0.746999979019165},{"id":"https://openalex.org/keywords/chronic-psychosis","display_name":"chronic psychosis","score":0.49000000953674316}],"concepts":[{"id":"https://openalex.org/C2780648746","wikidata":"https://www.wikidata.org/wiki/Q28208871","display_name":"Glutamatergic","level":4,"score":0.780449628829956},{"id":"https://openalex.org/C2777756961","wikidata":"https://www.wikidata.org/wiki/Q620730","display_name":"Glycine","level":3,"score":0.7350700497627258},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.6995278596878052},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.6559507250785828},{"id":"https://openalex.org/C67018056","wikidata":"https://www.wikidata.org/wiki/Q414896","display_name":"NMDA receptor","level":3,"score":0.6317021250724792},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5491150617599487},{"id":"https://openalex.org/C2779727114","wikidata":"https://www.wikidata.org/wiki/Q170082","display_name":"Psychosis","level":2,"score":0.48770222067832947},{"id":"https://openalex.org/C35599011","wikidata":"https://www.wikidata.org/wiki/Q426887","display_name":"Glycine receptor","level":4,"score":0.48114216327667236},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4033072590827942},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3472772240638733},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.34321510791778564},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.22251051664352417},{"id":"https://openalex.org/C61174792","wikidata":"https://www.wikidata.org/wiki/Q420510","display_name":"Glutamate receptor","level":3,"score":0.21505632996559143},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.21304762363433838},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.10931730270385742},{"id":"https://openalex.org/C515207424","wikidata":"https://www.wikidata.org/wiki/Q8066","display_name":"Amino acid","level":2,"score":0.0614449679851532},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000277","descriptor_name":"Adjuvants, Pharmaceutic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001480","descriptor_name":"Basal Ganglia Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D001480","descriptor_name":"Basal Ganglia Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001590","descriptor_name":"Benztropine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002908","descriptor_name":"Chronic Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003071","descriptor_name":"Cognition","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005998","descriptor_name":"Glycine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005998","descriptor_name":"Glycine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006220","descriptor_name":"Haloperidol","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006220","descriptor_name":"Haloperidol","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008152","descriptor_name":"Loxapine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008152","descriptor_name":"Loxapine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010865","descriptor_name":"Pilot Projects","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D013888","descriptor_name":"Thiothixene","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013888","descriptor_name":"Thiothixene","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014810","descriptor_name":"Vitamin E","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/00002826-198910000-00006","doi":"https://doi.org/10.1097/00002826-198910000-00006","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00002826-198910000-00006","pdf_url":null,"source":{"id":"https://openalex.org/S3349026","display_name":"Clinical Neuropharmacology","issn_l":"0362-5664","issn":["0362-5664","1537-162X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Neuropharmacology","raw_type":"journal-article"},{"id":"pmid:2611765","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2611765","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical neuropharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2121357459","https://openalex.org/W2022180773","https://openalex.org/W1244863148","https://openalex.org/W2112218294","https://openalex.org/W2411457149","https://openalex.org/W1980099177","https://openalex.org/W2319643143","https://openalex.org/W2068898125","https://openalex.org/W2299473164","https://openalex.org/W118066032"],"abstract_inverted_index":{"In":[0,90],"an":[1,20,39],"open-label":[2],"study,":[3],"glycine":[4,100,112,128,136,167],"was":[5,36,69,117,132],"administered":[6,37],"orally":[7],"(10.8":[8],"g/day":[9],"in":[10,38,59,83,108,114,138,151],"three":[11,152],"divided":[12],"doses)":[13],"to":[14,22,32,41,179],"six":[15,155],"chronically":[16],"psychotic":[17],"patients,":[18,85],"as":[19],"adjunct":[21],"conventional":[23],"neuroleptic":[24],"therapy,":[25],"for":[26],"periods":[27],"extending":[28],"from":[29],"4":[30],"days":[31],"8":[33],"weeks.":[34],"Glycine":[35,142],"effort":[40],"facilitate":[42],"endogenous":[43],"glutamatergic":[44,57,181],"transmission":[45,182],"at":[46,183],"the":[47,50,60,93,121,126,139,154,160,169,184,187],"level":[48,185],"of":[49,62,92,153,166,176,186],"N-methyl-D-aspartate":[51],"(NMDA)":[52],"receptor":[53,189],"complex,":[54],"since":[55],"a":[56,104,173],"deficiency":[58],"pathophysiology":[61],"schizophrenia":[63],"has":[64],"been":[65],"postulated.":[66],"Therapeutic":[67],"efficacy":[68],"assessed":[70],"with":[71,103,120],"standardized":[72],"psychiatric":[73],"rating":[74],"scales.":[75],"Beneficial":[76],"effects":[77],"on":[78],"behavioral":[79],"symptomatology":[80],"were":[81],"observed":[82,134],"two":[84,87,94],"whereas":[86],"others":[88],"worsened.":[89],"one":[91],"responders,":[95],"clinical":[96,122,161],"deterioration":[97],"occurred":[98],"after":[99,135],"withdrawal":[101],"consistent":[102],"positive":[105],"adjuvant":[106],"effect":[107],"this":[109,115,177],"patient.":[110],"However,":[111],"rechallenge":[113],"patient":[116],"not":[118,133],"associated":[119],"improvement":[123],"seen":[124],"during":[125],"initial":[127],"period.":[129],"Clinical":[130],"worsening":[131],"discontinuation":[137],"second":[140],"responder.":[141],"administration":[143],"reduced":[144],"neuroleptic-induced":[145],"muscle":[146],"stiffness":[147],"and":[148],"extrapyramidal":[149],"dysfunction":[150],"patients.":[156],"All":[157],"patients":[158],"tolerated":[159],"trial.":[162],"The":[163],"limited":[164],"penetrability":[165],"across":[168],"blood-brain":[170],"barrier":[171],"is":[172],"major":[174],"limitation":[175],"approach":[178],"facilitating":[180],"NMDA":[188],"complex.":[190]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":3},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":4}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}